Skip to content

VENTILATION DURING SPACEFLIGHT (PHASE 2)

VENTILATION DURING SPACEFLIGHT (PHASE 2)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07435389
Acronym
VESPA-2
Enrollment
12
Registered
2026-02-27
Start date
2026-09-16
Completion date
2026-09-20
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-invasive Ventilation

Brief summary

Space flights expose astronauts to medical risks, particularly respiratory risks, which are exacerbated in microgravity. Devices such as standard oxygen therapy and non-invasive ventilation (NIV) are used, but their performance in microgravity remains poorly studied. Parabolic flights allow these technologies to be evaluated in conditions similar to those encountered during space missions. In an initial study conducted in microgravity during a parabolic flight campaign, the T1 ventilator proved superior to the other devices tested on the test bench. However, its performance in healthy volunteers has not yet been evaluated. The central hypothesis of this exploratory study on healthy volunteers is that non-invasive ventilation, particularly with the CaStar UP helmet (Intersurgical), could offer superior performance to the standard oxygen mask in microgravity, thanks to better leak reduction (data from preclinical work on a test bench).

Interventions

DEVICEnon-invasive oxygenation strategies

A. Non-invasive ventilation with T1 ventilator (Hamilton) and BiTrac mask (Intersurgical): specific settings (AI 10 cmH2O, PEEP 5 cmH2O, FiO2 21%, etc.). B. Non-invasive ventilation with T1 ventilator (Hamilton) and CaStar UP helmet (Intersurgical): specific settings (AI 10 cmH2O, PEEP 5 cmH2O, FiO2 21%, etc.). C. Standard oxygen therapy without EcoLite gas mask (Intersurgical)

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

Exploratory study comparing the effectiveness of three non-invasive oxygenation support strategies on three groups of four people

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers (male or female) * Aged 18 to 65 * Affiliated with a Social Security scheme and, for non-French residents, holders of a European Health Insurance Card (EHIC) or a Global Health Insurance Card (GHIC) * Agreeing to participate in the study * Agreeing to participate in the study * Having given their informed consent in writing * Who have undergone a medical examination similar to a standard aeronautical medical examination for private pilot fitness

Exclusion criteria

* Individuals who have participated in a previous biomedical research protocol * whose exclusion period has not ended. * Individuals in a subordinate relationship with the principal investigator or scientific director. * Pregnant or breastfeeding women (urine pregnancy test for women of childbearing age). * Protected adults (under guardianship, curatorship, or judicial protection) * Flu-like symptoms, digestive symptoms (nausea, vomiting), fever. * Altered mental state (flight-related anxiety, phobic state). * Failure to attend the Novespace safety briefing.

Design outcomes

Primary

MeasureTime frame
Expiratory tidal volume24 hours

Countries

France

Contacts

CONTACTAndreia CARVALHO DE FREITAS
projet-recherche-clinique@chr-metz-thionville.fr0033387553323

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026